Overview Dividends

(OHI) Omega Healthcare Investors - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6819361006

Skilled Nursing, Assisted Living, Care Homes, REIT

EPS (Earnings per Share)

EPS Growth (3y CAGR): 50.87%
EPS Trend (3y Corr): 87.7%

Last SUE: 1.59σ
Qual. Beats: 2

Revenue

Revenue Growth (3y CAGR): 32.12%
Revenue Trend (3y Corr): 82.1%

Last SUE: 0.80σ
Qual. Beats: 0

Risk via 10d forecast
Volatility	20.3%
Value at Risk 5%th	31.9%
Relative Tail Risk	-4.14%

Reward TTM
Sharpe Ratio	0.82
Alpha	13.63

Character TTM
Hurst Exponent	0.325
Beta	0.182
Beta Downside	0.184

Drawdowns 3y
Max DD	15.47%
Mean DD	5.22%
Median DD	5.25%

Description: OHI Omega Healthcare Investors October 31, 2025

Omega Healthcare Investors, Inc. (NYSE: OHI) is a publicly traded REIT that finances and owns long-term care properties-primarily skilled-nursing and assisted-living facilities-in the United States and the United Kingdom. As of June 30 2025 the company’s portfolio comprised 1,032 operating facilities across 42 U.S. states, D.C., and the U.K./Jersey, with 289 of those located abroad, and they are managed by 92 distinct operators.

Key performance indicators that investors watch include a reported occupancy rate of roughly 84% (Q2 2025), a dividend yield near 7.2%, and funds-from-operations (FFO) growth of 5% year-over-year, while leverage remains around 6.5× EBITDA. The sector’s outlook is driven by macro trends such as the aging-population boom (U.S. adults 65+ projected to reach 22% by 2035), tightening Medicare/Medicaid reimbursement rules, and the sensitivity of REIT financing costs to prevailing interest-rate movements.

If you want a data-rich, side-by-side comparison of OHI’s valuation and risk metrics against its peers, the ValueRay platform provides a free, interactive dashboard that can help you dig deeper.

OHI Stock Overview

Market Cap in USD	13,197m
Sub-Industry	Health Care REITs
IPO / Inception	1992-08-07
Return 12m vs S&P 500	5.04%
Analyst Rating	3.69 of 5

OHI Dividends

Metric	Value
Dividend Yield	5.99%
Yield on Cost 5y	11.56%
Yield CAGR 5y	0.00%
Payout Consistency	87.3%
Payout Ratio	141.2%

OHI Growth Ratios

Metric	Value
CAGR 3y	23.10%
CAGR/Max DD Calmar Ratio	1.49
CAGR/Mean DD Pain Ratio	4.42
Current Volume	1784.4k
Average Volume	1775.3k

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (543.9m TTM) > 0 and > 6% of Revenue (6% = 69.0m TTM)

FCFTA 0.08 (>2.0%) and ΔFCFTA 1.13pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 213.1% (prev 202.0%; Δ 11.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.08 (>3.0%) and CFO 876.2m > Net Income 543.9m (YES >=105%, WARN >=100%)

Net Debt (4.26b) to EBITDA (1.03b) ratio: 4.12 <= 3.0 (WARN <= 3.5)

Current Ratio 7.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (308.2m) change vs 12m ago 11.84% (target <= -2.0% for YES)

Gross Margin 98.83% (prev 98.58%; Δ 0.24pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 11.41% (prev 10.57%; Δ 0.84pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.26 (EBITDA TTM 1.03b / Interest Expense TTM 218.5m) >= 6 (WARN >= 3)

Altman Z'' 0.21

(A) 0.23 = (Total Current Assets 2.81b - Total Current Liabilities 357.4m) / Total Assets 10.60b

(B) -0.34 = Retained Earnings (Balance) -3.59b / Total Assets 10.60b

(D) -0.65 = Book Value of Equity -3.48b / Total Liabilities 5.35b

Total Rating: 0.21 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 72.49

1. Piotroski 4.0pt = -1.0

2. FCF Yield 4.82% = 2.41

3. FCF Margin 73.11% = 7.50

4. Debt/Equity 0.99 = 2.03

5. Debt/Ebitda 4.12 = -2.50

6. ROIC - WACC (= 2.06)% = 2.57

7. RoE 11.27% = 0.94

8. Rev. Trend 82.05% = 6.15

9. EPS Trend 87.70% = 4.39

What is the price of OHI shares?

As of November 20, 2025, the stock is trading at USD 44.72 with a total of 1,784,442 shares traded.
Over the past week, the price has changed by +2.40%, over one month by +10.71%, over three months by +10.11% and over the past year by +19.35%.

Is OHI a buy, sell or hold?

Omega Healthcare Investors has received a consensus analysts rating of 3.69. Therefor, it is recommend to hold OHI.

Strong Buy: 4
Buy: 3
Hold: 9
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the OHI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	45.3	1.4%
Analysts Target Price	45.3	1.4%
ValueRay Target Price	55.1	23.3%

OHI Fundamental Data Overview November 17, 2025

Market Cap USD = 13.20b (13.20b USD * 1.0 USD.USD)
P/E Trailing = 24.4278
P/E Forward = 10.1317
P/S = 11.4741
P/B = 2.5802
P/EG = 1.13
Beta = 0.562
Revenue TTM = 1.15b USD
EBIT TTM = 713.2m USD
EBITDA TTM = 1.03b USD
Long Term Debt = 4.99b USD (from longTermDebt, last quarter)
Short Term Debt = 879.1m USD (from shortTermDebt, last fiscal year)
Debt = 4.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.26b USD (from netDebt column, last quarter)
Enterprise Value = 17.45b USD (13.20b + Debt 4.99b - CCE 737.2m)
Interest Coverage Ratio = 3.26 (Ebit TTM 713.2m / Interest Expense TTM 218.5m)
FCF Yield = 4.82% (FCF TTM 840.9m / Enterprise Value 17.45b)
FCF Margin = 73.11% (FCF TTM 840.9m / Revenue TTM 1.15b)
Net Margin = 47.29% (Net Income TTM 543.9m / Revenue TTM 1.15b)
Gross Margin = 98.83% ((Revenue TTM 1.15b - Cost of Revenue TTM 13.5m) / Revenue TTM)
Gross Margin QoQ = 98.88% (prev 98.85%)
Tobins Q-Ratio = 1.65 (Enterprise Value 17.45b / Total Assets 10.60b)
Interest Expense / Debt = 1.16% (Interest Expense 58.1m / Debt 4.99b)
Taxrate = 2.34% (4.48m / 191.3m)
NOPAT = 696.5m (EBIT 713.2m * (1 - 2.34%))
Current Ratio = 7.86 (Total Current Assets 2.81b / Total Current Liabilities 357.4m)
Debt / Equity = 0.99 (Debt 4.99b / totalStockholderEquity, last quarter 5.04b)
Debt / EBITDA = 4.12 (Net Debt 4.26b / EBITDA 1.03b)
Debt / FCF = 5.06 (Net Debt 4.26b / FCF TTM 840.9m)
Total Stockholder Equity = 4.83b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.13% (Net Income 543.9m / Total Assets 10.60b)
RoE = 11.27% (Net Income TTM 543.9m / Total Stockholder Equity 4.83b)
RoCE = 7.26% (EBIT 713.2m / Capital Employed (Equity 4.83b + L.T.Debt 4.99b))
RoIC = 7.22% (NOPAT 696.5m / Invested Capital 9.65b)
WACC = 5.17% (E(13.20b)/V(18.19b) * Re(6.69%) + D(4.99b)/V(18.19b) * Rd(1.16%) * (1-Tc(0.02)))
Discount Rate = 6.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 9.60%
[DCF Debug] Terminal Value 79.04% ; FCFE base≈765.1m ; Y1≈806.5m ; Y5≈950.8m
Fair Price DCF = 56.37 (DCF Value 16.66b / Shares Outstanding 295.5m; 5y FCF grow 5.91% → 3.0% )
EPS Correlation: 87.70 | EPS CAGR: 50.87% | SUE: 1.59 | # QB: 2
Revenue Correlation: 82.05 | Revenue CAGR: 32.12% | SUE: 0.80 | # QB: 0

Additional Sources for OHI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle